NBIX

Neurocrine Biosciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD170.00

+1.48 (+0.88%)

Rating:A

Company Profile

CEO

Kyle W. Gano

IPO Date

1996-05-23

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$168.83

Prev. Close

$168.52

Day Low

$168.83

Day High

$171.43

52W Low

$122.14

52W High

$171.43

Market Cap

$17.09B

Volume

1.35M

News SentimentNeutral

Articles

Avg Positive

11.8%

Avg Negative

12.8%

Avg Neutral

75.5%

News Feed

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results

PRNewsWire·7/19/2021·↑ positive

Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference

PRNewsWire·7/8/2021·↑ positive

Neurocrine Biosciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

PRNewsWire